Therapies for acute myeloid leukemia: vosaroxin
Sign Up to like & getrecommendations! Published in 2017 at "OncoTargets and therapy"
DOI: 10.2147/ott.s121477
Abstract: Vosaroxin, a quinolone-derivative chemotherapeutic agent, was considered a promising drug for the treatment of acute myeloid leukemia (AML). Early-stage clinical trials with this agent led to a large randomized double-blind placebo-controlled study of vosaroxin in… read more here.
Keywords: myeloid leukemia; vosaroxin; acute myeloid; therapies acute ... See more keywords